EP3700529
Ný samsetning af virkum miðlum til meðhöndlunar á ágengum trefjandi millivefslungnasjúkdómum (PF-ILD)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
12.10.2018EP published:
9.7.2025EP application number:
18785961.6
EP translation filed:
8.9.2025Grant published:
15.10.2025EPO information:
European Patent Register
Max expiry date:
11.10.2038Expiry date:
11.10.2026Next due date:
31.10.2026
Title in English:
NEW COMBINATION OF ACTIVE AGENTS FOR THE TREATMENT OF PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (PF-ILD)Language of the patent:
English
Timeline
Today
12.10.2018EP application
9.7.2025EP Publication
8.9.2025Translation submitted
15.10.2025Registration published
11.10.2026Expires
Owner
Name:
Boehringer Ingelheim International GmbHAddress:
Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Inventor
Name:
HERRMANN, Franziska, ElenaAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
NICKOLAUS, PeterAddress:
55216 INGELHEIM AM RHEIN, DE
Name:
WOLLIN, Stefan, Ludwig, MichaelAddress:
55216 INGELHEIM AM RHEIN, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
17197719Date:
23.10.2017Country:
EP
Classification
Categories:
A61K 31/505, A61K 31/519, A61P 11/00, A61K 31/496
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 13.10.2025
Expires: 11.10.2026
Payer: G.H. Sigurgeirsson ehf.